This epigenetic control results in the modulation of genes involved in HCC progression, such as Ras association domain family member 1 (RASSF1), GATA binding protein 4 (GATA4), and cyclin dependent kinase like 2 (CDKL2) [242,250]. The gene discussed is RASSF1; the disease is hepatocellular carcinoma.